Error message

The page you requested does not exist. For your convenience, a search was performed using the query Cardiovascular Metabolism.

Page not found

Search results

  1. From Chemical to Drug- The Path to a Small Molecule IND

    Quantitative Sciences Therapeutic Area Leader, Cardiovascular & Metabolism, Janssen R&D read bio» ... including infectious, metabolic and cardiovascular diseases, immunology, neuroscience and oncology. She has ... Cardiovascular & Metabolism, Janssen R&D Ken received his BA degree in Chemistry and his Ph.D. degree ...

  2. From Chemical to Drug- The Path to a Small Molecule IND

    Quantitative Sciences Therapeutic Area Leader, Cardiovascular & Metabolism, Janssen R&D read bio» ... She has worked across therapeutic areas including infectious, metabolic and cardiovascular diseases, ... Quantitative Sciences Therapeutic Area Leader, Cardiovascular & Metabolism, Janssen R&D Ken received ...

  3. Alan Koder

    he focused gene expression and new drug development to treat inflammatory, cardiovascular ... and metabolic diseases. Alan has a BS in Biochemistry and Cell Biology from the University of California, San ...

  4. The Road to the Clinic for Small Molecule

    is responsible for a portfolio of preclinical projects in the Oncology, Cardiovascular and Metabolism therapeutic ... Sciences Therapeutic Area Leader for the Cardiovascular & Metabolism Therapeutic Area. ^ Back ... Development- Overview Preclinical Development strategies for pharmacokinetics, drug metabolism and toxicology ...

  5. Alumni

    Focus: Cardiovascular/Metabolism A powerful therapeutic approach targeting the central regulator of nutrient signaling, cellular ... for a specific drug. We are focused on improving drug efficacy in oncology, metabolic disorders, cardiovascular ... complicate cancer and transplant treatments Clinical Metabolics (Clinmet) ClinMet uses metabolomics ...

  6. ABCs of the FDA – How to… Set a Preclinical Roadmap

    Cardiovascular and Metabolism therapeutic areas. Mike is also the Janssen R&D preclinical scientific liaison ... drug metabolism, pharmacokinetic and toxicology characteristics that should be considered in molecule ...

  7. ABCs of the FDA – How to… Set a Preclinical Roadmap [At the door]

    and development projects in the Oncology, Cardiovascular and Metabolism therapeutic areas. Mike is also ... startups. Topics will include: Key drug metabolism, pharmacokinetic and toxicology characteristics ...

  8. ABCs of the FDA- How to… Set a Preclinical Roadmap

    will include:    - Key drug metabolism, pharmacokinetic and toxicology characteristics that should ... is responsible for a portfolio of discovery and development projects in the Oncology, Cardiovascular ... and Metabolism therapeutic areas. Mike is also the Janssen R&D preclinical scientific liaison to the Johnson ...

  9. Sell Your Science- Best Practices for Developing an Effective Non-Confidential Pitch Deck

    Innovation, Boston. He focuses primarily on cardiovascular & metabolic; infectious diseases and Vaccines; ...

  10. Sell Your Science- Best Practices for Developing an Effective Non-Confidential Pitch Deck

    & Johnson Innovation, Boston. He focuses primarily on cardiovascular & metabolic; infectious ...

Pages

Share